News
New Data Supports Clinical Rationale for Bertilimumab in Ulcerative Colitis
Immune Pharmaceuticals Inc. announced today that Tomer Adar, M.D. at the Digestive Diseases Institute, Shaare Zedek Medical Center, Hebrew University of Jerusalem, presented a poster...
News
Construction of Facilities for 12 Key Projects Breaks Ground in Changzhou National Hi-Tech District
Construction of the facilities for the third group of twelve key projects scheduled for this year got underway recently in Changzhou National Hi-Tech District (CND),...
News
Pluristem’s PLX Cells Demonstrate Efficacy in Preclinical Study for Graft versus Host Disease
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapies, announced today that the company''s PLacental eXpanded (PLX) cells demonstrated efficacy in a preliminary animal...
News
Given Imaging Receives Clearance for the Third Generation PillCam(R) SB System in Japan
Given Imaging Ltd, a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that Japan''s Pharmaceuticals and Medical Devices Agency (PMDA)...
News
ActiveCare Strengthens Balance Sheet With Closing of Equity Investment and Debt Conversion
ActiveCare, Inc.,a service leader in disease and diabetes management, today announced the closing of an equity investment and conversion of debt to common stock. In...
News
Safebrain Systems Inc. Announces a Renewed Partnership With Arizona State Hockey Program
Safebrain Systems Inc. (OTCQB:SFBR) President and CEO Michael Scott is extremely excited to announce that the Arizona State Hockey program has partnered with SafeBrain for...
News
Boston Scientific Launches OptiCross Coronary Imaging Catheter in US, Europe and Japan
The Boston Scientific Corporation announced that it has received U.S. Food and Drug Administration clearance, CE Mark and Japan PMDA approval for its OptiCross™ Coronary...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.

















